This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
The Cooper Companies Inc (COO), based in Pleasanton, CA, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision (CVI) and CooperSurgical (CSI). CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company’s products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness. CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians. This strategic business unit has pursued a strategy of consolidation by acquiring critical treatment niches in a fragmented market.
Zacks.com featured highlights include: Novavax, The Cooper Companies, Veeco Instruments and Maxar Technologies
by Zacks Equity Research
Zacks.com featured highlights include: Novavax, The Cooper Companies, Veeco Instruments and Maxar Technologies
Marvell (MRVL) to Post Q2 Earnings: What Lies in Store?
by Zacks Equity Research
Marvell's (MRVL) fiscal second-quarter results are likely to be hurt by a weak storage and networking business. However, the Cavium business is likely to be a key growth driver.
XRAY or COO: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
XRAY vs. COO: Which Stock Is the Better Value Option?
What's in Store for Cooper Companies (COO) in Q3 Earnings?
by Zacks Equity Research
Better-than-expected performance at CVI and CSI and higher revenues are likely to aid Cooper Companies (COO) in Q3 earnings.
Factors Likely to Influence Workday's (WDAY) Q2 Earnings
by Zacks Equity Research
Workday's (WDAY) revenue growth continues to be driven by high demand for its HCM and financial management solutions. Also, its diversified product portfolio is a positive.
What's in Store for Patterson Companies (PDCO) in Q1 Earnings?
by Zacks Equity Research
Patterson Companies (PDCO) expects Dental and Animal Health arms to boost first-quarter fiscal 2020 results.
Ambarella (AMBA) to Post Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Ambarella (AMBA) second-quarter fiscal 2020 results are likely to gain from strong design wins and improving customer engagement.
4 Stocks That Boast Superb Earnings Acceleration
by Tirthankar Chakraborty
Studies have shown that a majority of stocks had seen acceleration in earnings before a rally in stock price.
Greif (GEF) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Ongoing focus on operational execution and the Caraustar acquisition will likely aid Greif's (GEF) third-quarter fiscal 2019 results.
Cooper Cos. (COO) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Cooper Cos. (COO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nutanix (NTNX) to Post Q4 Earnings: What Lies in Store?
by Zacks Equity Research
Nutanix's (NTNX) fourth-quarter fiscal 2019 results are likely to benefit from growing customer base. However, extended sales cycles due to transition to a subscription-based model are a concern.
What's in the Offing for Veeva Systems (VEEV) in Q2 Earnings?
by Zacks Equity Research
Robust product portfolio and higher revenues are likely to aid Veeva Systems (VEEV) in second-quarter fiscal 2020 earnings.
Veeva Systems (VEEV) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
Veeva's (VEEV) core Subscription Services unit likely to drive Q2 results.
The Zacks Analyst Blog Highlights: Sea, Target, 1-800-FLOWERS.COM, Burlington and Cooper Companies
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Sea, Target, 1-800-FLOWERS.COM, Burlington and Cooper Companies
Intuit (INTU) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Intuit's (INTU) fourth-quarter fiscal 2019 results are likely to gain from the growing adoption of QuickBooks Online. However, slowdown in revenues from the tax business is expected to be an overhang.
Medtronic (MDT) to Post Q1 Earnings: Will RTG Aid the Stock?
by Zacks Equity Research
Medtronic (MDT) is encouraged by robust and consistent constant currency growth in the RTG business over the last few quarters.
HP (HPQ) to Post Q3 Earnings: What Lies Ahead for the Stock?
by Zacks Equity Research
HP's (HPQ) third-quarter fiscal 2019 results are likely to be driven by growth in its commercial PC revenues amid waning consumer demand.
5 Must-Buy Stocks Ahead of Earnings Results This Month
by Nalak Das
Second-quarter 2019 earnings results have so far come in better than expected.
salesforce (CRM) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
salesforce's (CRM) Q2 fiscal 2020 results are likely to benefit from a buoyant demand landscape for its cloud offerings. However, steep expenses and unfavorable forex volatility are key challenges.
Pure Storage (PSTG) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
Pure Storage's (PSTG) robust adoption of FlashArray & FlashBlade solutions is driving growth. However, currency headwinds, and high tariffs owing to trade war between the U.S. and China remains headwind.
What's in the Offing for Keysight (KEYS) in Q3 Earnings?
by Zacks Equity Research
Keysight (KEYS) rides on robust adoption driven by high demand for 5G design and test solutions primarily from telecom vendors, and a strong pipeline for new business bookings.
Zayo (ZAYO) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Zayo's (ZAYO) fiscal fourth-quarter results are likely to benefit from a diversified blue-chip customer base that comprises the largest and most sophisticated users of bandwidth.
Synopsys (SNPS) to Post Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Synopsys' (SNPS) third-quarter fiscal 2019 results are likely to benefit from the increasing uptake of its strong product portfolio. However, Huawei ban remains a major headwind for the company.
Medtronic (MDT) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Medtronic's (MDT) successful execution of growth policies should aid earnings results in the fiscal first quarter.
Factors Setting the Tone for Cree (CREE) in Q4 Earnings
by Zacks Equity Research
Cree's (CREE) fourth-quarter fiscal 2019 results are likely to benefit from ongoing momentum in Wolfspeed business amid Huawei blacklisting and other macroeconomic headwinds.